TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Reviva Bio AB
Closing information (x1000 NOK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
41,733
|
18,502
|
12,208 |
| Financial expenses |
121
|
6
|
0 |
| Earnings before taxes |
8,402
|
1,458
|
1,227 |
| EBITDA |
9,391
|
1,559
|
1,313 |
| Total assets |
24,806
|
13,108
|
7,072 |
| Current assets |
17,126
|
12,775
|
6,787 |
| Current liabilities |
7,209
|
6,520
|
1,498 |
| Equity capital |
12,874
|
5,843
|
4,848 |
| - share capital |
54
|
50
|
52 |
| Employees (average) |
19
|
11
|
8 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
51.9%
|
44.6%
|
68.6% |
| Turnover per employee |
2,196
|
1,682
|
1,526 |
| Profit as a percentage of turnover |
20.1%
|
7.9%
|
10.1% |
| Return on assets (ROA) |
34.4%
|
11.2%
|
17.4% |
| Current ratio |
237.6%
|
195.9%
|
453.1% |
| Return on equity (ROE) |
65.3%
|
25.0%
|
25.3% |
| Change turnover |
21,923
|
6,664
|
1,409 |
| Change turnover % |
111%
|
56%
|
13% |
| Chg. No. of employees |
8
|
3
|
0 |
| Chg. No. of employees % |
73%
|
38%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.